$7.94
4.57% today
Nasdaq, Apr 03, 06:47 pm CET
ISIN
US89455T1097
Symbol
TMCI

Treace Medical Concepts Inc Target price 2025 - Analyst rating & recommendation

Treace Medical Concepts Inc Classifications & Recommendation:

Buy
29%
Hold
71%

Treace Medical Concepts Inc Price Target

Target Price $11.29
Price $8.32
Potential
Number of Estimates 7
7 Analysts have issued a price target Treace Medical Concepts Inc 2026 . The average Treace Medical Concepts Inc target price is $11.29. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 2 Analysts recommend Treace Medical Concepts Inc to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Treace Medical Concepts Inc stock has an average upside potential 2026 of . Most analysts recommend the Treace Medical Concepts Inc stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 209.36 227.53
11.89% 8.68%
EBITDA Margin -22.58% 0.17%
8.31% 100.75%
Net Margin -26.81% -22.06%
0.69% 17.71%

7 Analysts have issued a sales forecast Treace Medical Concepts Inc 2025 . The average Treace Medical Concepts Inc sales estimate is

$228m
Unlock
. This is
8.68% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$229m 9.58%
Unlock
, the lowest is
$227m 8.23%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $209m 11.89%
2025
$228m 8.68%
Unlock
2026
$250m 10.08%
Unlock
2027
$273m 8.95%
Unlock

7 Analysts have issued an Treace Medical Concepts Inc EBITDA forecast 2025. The average Treace Medical Concepts Inc EBITDA estimate is

$397k
Unlock
. This is
100.84% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$3.4m 107.21%
Unlock
, the lowest is
$-1.7m 96.40%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-47.3m 2.58%
2025
$397k 100.84%
Unlock
2026
$8.0m 1,907.33%
Unlock
2027
$20.2m 153.02%
Unlock

EBITDA Margin

2024 -22.58% 8.31%
2025
0.17% 100.75%
Unlock
2026
3.18% 1,770.59%
Unlock
2027
7.39% 132.39%
Unlock

4 Treace Medical Concepts Inc Analysts have issued a net profit forecast 2025. The average Treace Medical Concepts Inc net profit estimate is

$-50.2m
Unlock
. This is
10.56% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-48.6m 13.33%
Unlock
, the lowest is
$-53.0m 5.55%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-56.1m 11.11%
2025
$-50.2m 10.56%
Unlock
2026
$-45.2m 9.90%
Unlock
2027
$-45.4m 0.38%
Unlock

Net Margin

2024 -26.81% 0.69%
2025
-22.06% 17.71%
Unlock
2026
-18.06% 18.13%
Unlock
2027
-16.64% 7.86%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.90 -0.80
11.11% 11.11%
P/E negative
EV/Sales 2.26

4 Analysts have issued a Treace Medical Concepts Inc forecast for earnings per share. The average Treace Medical Concepts Inc EPS is

$-0.80
Unlock
. This is
11.11% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.78 13.33%
Unlock
, the lowest is
$-0.85 5.56%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.90 11.11%
2025
$-0.80 11.11%
Unlock
2026
$-0.73 8.75%
Unlock
2027
$-0.73 0.00%
Unlock

P/E ratio

Current -9.26 42.13%
2025
-10.34 11.66%
Unlock
2026
-11.47 10.93%
Unlock
2027
-11.43 0.35%
Unlock

Based on analysts' sales estimates for 2025, the Treace Medical Concepts Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.46 38.81%
2025
2.26 8.00%
Unlock
2026
2.06 9.16%
Unlock
2027
1.89 8.21%
Unlock

P/S ratio

Current 2.49 42.22%
2025
2.29 7.99%
Unlock
2026
2.08 9.16%
Unlock
2027
1.91 8.21%
Unlock

Current Treace Medical Concepts Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Truist Securities
Locked
Locked
Locked Mar 13 2025
Truist Securities
Locked
Locked
Locked Mar 03 2025
Lake Street
Locked
Locked
Locked Dec 31 2024
Truist Securities
Locked
Locked
Locked Dec 18 2024
Stifel
Locked
Locked
Locked Nov 06 2024
Truist Securities
Locked
Locked
Locked Oct 14 2024
Analyst Rating Date
Locked
Truist Securities:
Locked
Locked
Mar 13 2025
Locked
Truist Securities:
Locked
Locked
Mar 03 2025
Locked
Lake Street:
Locked
Locked
Dec 31 2024
Locked
Truist Securities:
Locked
Locked
Dec 18 2024
Locked
Stifel:
Locked
Locked
Nov 06 2024
Locked
Truist Securities:
Locked
Locked
Oct 14 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today